Enzyme-linked immunosorbent assay (ELISA) testing Market - Global Industry Analysis

Enzyme-linked immunosorbent assay (ELISA) testing Market

Enzyme-linked immunosorbent assay (ELISA) testing Market by Test type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA) By Application (Immunology, Inflammation, Infectious diseases, Cancer, Protein quantification, and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 08-Jun-2021 Category: Pharmaceutical Report Format : PDF Pages: 140 Report Code: ZMR-1978 Status : Published

The global Enzyme-linked immunosorbent assay (ELISA) testing market accounted for USD 513.4 Million in 2020 and is expected to reach USD 725.6 Million by 2028, growing at a CAGR of around 4.4 % between 2021 and 2028.

Enzyme-linked immunosorbent assay (ELIS Market

Description

Market Overview

The global Enzyme-linked immunosorbent assay (ELISA) testing market accounted for USD 513.4 Million in 2020 and is expected to reach USD 725.6 Million by 2028, growing at a CAGR of around 4.4 % between 2021 and 2028. 

The global Enzyme-linked immunosorbent assay (ELISA) Market is a test that detects and/or quantifies antibodies in biological samples. This test can be used to determine if the sample has antibodies related to or generated against a specific antigen related to a certain infectious condition. Antibodies are proteins that are produced against foreign pathogens as an immunogenic response to harmful substances called pathogens. ELISA is a biochemical reaction in which an antigen is adsorbed on a solid surface. An antibody linked to an enzyme is allowed with the antigen and is detected by adding a substrate specific to the linked enzyme. ELISA test plays very important role in the diagnosis of viral infections such as HIV, varicella-zoster virus, which causes chickenpox and shingles, rotavirus, Zika virus, syphilis etc. ELISA is often used as a screening tool before more in-depth tests are carried out. ELISA also can be used in pharmaceutical quality control tests such as endotoxin tests, protein quantification.    

COVID-19 Impact Analysis:

The restrictions imposed by various nations to contain COVID had stopped the demand and supply resulting in disruption across the whole supply chain. However, the global markets are slowly opening to their full potential, and theirs a surge in demand. The market would remain bullish in the upcoming year.  The significant decrease in the global Enzyme-linked immunosorbent assay (ELISA) testing market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

To know more about this report, request a sample copy.

Growth Factors

The global Enzyme-Linked Immunosorbent Assay (ELISA) testing market is primarily driven by the emergence of cost-effective technologies and laboratory automation for ELISA assay. Other major driving factors are increasing research and development on biomarkers and monoclonal antibodies (mABs) coupled with continued growth in the drug discovery market. However, the threat of substitution by new technologies such as multiplex proteomic array platforms is the major restraint that may limit the growth of the market. Nonetheless increasing the need for accurate and early disease diagnosis owing to the increasing burden of chronic diseases across the globe along with the increasing geriatric population base are likely to disclose new avenues for the Enzyme-Linked Immunosorbent Assay (ELISA) testing market in the near future.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is segmented on the basis of different test types such as Test type, indirect ELISA, multiple and portable ELISA, and competitive ELISA. The indirect ELISA segment is expected to grow at the fastest rate in the global market over the forecast period.

Immunology, inflammation, infectious diseases, cancer, protein quantification, and others are the key applications of the global ELISA testing Market. The immunology segment dominated the market in terms of revenue in 2016.

To know more about this report, Request For Customization.

Key Market Players & Competitive Landscape

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global air quality control system market Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others..

 The global Enzyme-linked immunosorbent assay (ELISA) testing Market is segmented as follows:

By Test type

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and portable ELISA
  • Competitive ELISA

By Applications   

  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantification
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

Enzyme-Linked Immunosorbent Assay (ELISA) also called enzyme immunoassay (EIA) is a plate based assay technique for detection and quantification of substances such as proteins, hormones, antibodies etc. The ELISA has been used widely as an important diagnostic tool in medicine, plant pathology, as well as a quality-control check in pharmaceutical and biotech industries. ELISA assay technique is based on specific antigen antibody binding. Antigen to be quantified is immobilized (adsorbed) on a solid surface and is complexed with antibody linked to an enzyme. Detection is accomplished by assessing the conjugated enzyme activity via incubation with a substrate to produce a product that can be measured. ELISA has applications in various applications such as allergen detection in the food industry, viral infection diagnosis in the pathology laboratory and in quality control tests in the pharmaceutical industry.

The emergence of cost effective technologies and laboratory automation for ELISA assay is expected to be the major driver for the global ELISA technologies market. In addition, continuous developments in biomarkers and monoclonal antibodies (mABs) coupled along with continued growth in drug discovery market is expected to trigger the growth of global ELISA technologies industry in the coming years. However, the threat of substitution by new technologies such as multiplex proteomic array platforms may pose the challenge to ELISA technologies market. Nevertheless, increasing need for accurate and early disease diagnosis owing to increasing burden of chronic diseases across the globe along with increasing geriatric population base is expected to act as opportunities for ELISA technologies market in near future.

Based on test type, ELISA technologies market has been segmented into sandwich ELISA, indirect ELISA, multiple and portable ELISA and competitive ELISA. Indirect ELISA segment is expected to grow at the fastest rate during the forecast period. The ELISA technologies market is segmented based on applications into immunology, inflammation, infectious diseases, cancer, protein quantification and other applications. In terms of revenue, immunology segment dominated the market in 2016.  

North America is expected to remain the dominant region over the forecast period. Increasing healthcare expenditure is expected to boost the market in this region. Europe was the second largest market followed by Asia Pacific. North America is expected to show fastest growth rate during the forecast period while Asia Pacific market is projected to grow at the highest rate during the forecast period. The Middle East and Africa, and Latin America are also expected to experience moderate growth in the years to come.

Some of the key players in ELISA technologies market include Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.

FrequentlyAsked Questions

The global Enzyme-linked immunosorbent assay (ELISA) testing Market was valued at USD 513.4 Million in 2020.

The global Enzyme-linked immunosorbent assay (ELISA) testing Market is expected to reach USD 725.6 Million by 2028, growing at a CAGR of 4.4% between 2021 to 2028.

Some of the key factors driving the global Enzyme-linked immunosorbent assay (ELISA) testing Market growth are increasing research and development on biomarkers and monoclonal antibodies (mABs) coupled along with continued growth in drug discovery market.  

North America has been leading the worldwide Enzyme-linked immunosorbent assay (ELISA) testing market and is anticipated to continue on the dominant position in the years to come, states the market study.

Some of the major players of global Enzyme-linked immunosorbent assay (ELISA) testing market includes Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed